Navigation Links
The Epilepsy Market Will Grow 2 Percent Annually Through 2022 with Expanding Uptake of Third-Generation Brands
Date:12/16/2013

BURLINGTON, Mass., Dec. 16, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market for epilepsy pharmacotherapies will expand at a rate of 2 percent annually through 2022, peaking at more than $4.1 billion in 2020. Market growth will be fueled primarily by increasing uptake of premium-priced third-generation antiepileptic drugs (AEDs) such as UCB's Vimpat. Capturing approximately $800 million in 2021 sales across the major pharmaceutical markets under study (the United States, France, Germany, Italy, Spain, the United Kingdom and Japan), Vimpat will achieve the greatest clinical and commercial success in its class, capitalizing on a strong efficacy and safety profile that will drive its gradual incorporation into early lines of epilepsy treatment.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

Nevertheless, the Pharmacor advisory service entitled Epilepsy finds that neurologists will continue to rely heavily on time-tested, generically available, first- and second-generation AEDs, notably levetiracetam (UCB/Otsuka's Keppra/E Keppra, generics; UCB's Keppra XR, generics) and lamotrigine (GlaxoSmithKline/Juste's Lamictal, other brands, generics; GlaxoSmithKline's Lamictal XR, generics). In contrast, the findings reveal that the uptake of newly marketed brands—Eisai's Fycompa, Sunovion Pharmaceuticals/Bial/Eisai's Zebinix/Aptiom—and emerging novel therapies—UCB's brivaracetam—will be slow as prescribers gradually adopt these newer therapies as
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
2. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Epilepsy and other Neurological Disorders
3. New data from UCBs epilepsy portfolio to be highlighted at the 67th Annual Meeting of the American Epilepsy Society
4. Upsher-Smith To Present New Research On USL255 (Extended-Release Topiramate) At 2013 American Epilepsy Society Annual Meeting
5. Upsher-Smith To Present Findings From Global Phase 3 Trial Investigating USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures At 2013 American Epilepsy Society Meeting
6. GW Pharmaceuticals Commences Phase 1 Clinical Trial of GWP42006 as a Potential Treatment for Epilepsy
7. Epilepsy Foundation Calls on Drug Enforcement Agency to Improve Review Process for New Treatments
8. Upsher-Smith Teams Up With Epilepsy Foundation Of Minnesota For 2013 Stroll For Epilepsy
9. Epilepsy Foundation Launches The "Epilepsy Innovation Seal Of Excellence" Recognizing Groundbreaking Product Candidates For People With Epilepsy
10. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
11. Surveyed U.S. and European Neurologists Identify Better Seizure-Free Efficacy as One of the Greatest Unmet Needs in Treating Partial-Onset Seizures in Refractory Epilepsy Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... BETHESDA, Md. , May 28, 2015 /PRNewswire-USNewswire/ ... that it will be a supporting organization of ... assurance and sterilization in 2016. Johnson ... a series of high-profile superbug infections in endoscopes. ... world health issues between 1976 and 2003 on ...
(Date:5/28/2015)... , May 28, 2015 Compassion & Choices today ... approved a bill that would authorize the option of medical ... 5-2. The ... , would allow mentally competent adults with six months or ... could take to painlessly and peacefully end an unbearable dying ...
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "Personalized ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... is to match the right drug to ... even to design the appropriate treatment for ...
Breaking Medicine Technology:PDA Announces Support for the Johnson & Johnson Kilmer Conference 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: ... Food Allergy Awareness Week (FAAW), May 8-14. Created by the ... to educate others and raise awareness about food allergies, a ... are the most common trigger of anaphylaxis,(3) a severe allergic ...
... Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: ... radiotherapy and diagnostic imaging centers in China, today announced that ... The Company will present at the 16th CLSA ... 2011 at the Grand Hyatt Hotel in Beijing. Management will ...
Cached Medicine Technology:Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 2Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 3Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 4Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 5Dey Pharma Commemorates 14th Annual Food Allergy Awareness Week 6Concord Medical Services Holdings to Present at Two Upcoming Conferences 2
(Date:5/29/2015)... The world of dentistry had an image problem in ... who dispense pain to people unfortunate enough to need to ... came to surgeries, people would have to spend a lot ... back in the 20th Century now. Nowadays one need only ... Sheepshead Bay neighborhood of Brooklyn, New York to see ...
(Date:5/29/2015)... The 3D Certificate program is for senior managers, ... and engineering aspects of evaluating 3D technology. Any company ... in their existing 3D investment, or getting an education ... in manufacturing in various fields, will benefit greatly from ... that cover the following topics: state of the art ...
(Date:5/29/2015)... 2015 Acoustiblok recently resolved a noisy ... for Three Valleys Municipal Water District (Three Valleys MWD) ... working on the project said, “The new Acoustiblok All ... and are much better looking than the temporary barriers. ... helped us throughout the process, and the customer service ...
(Date:5/28/2015)... 29, 2015 Medical Device Cybersecurity ... Approaches, **FDAnews Webinar**, June 23, 2015 — 1:00 ... , Network connectivity opens up a wealth of ... a minefield of potential liabilities. Devices transmit data ... can manufacturers be sure the information doesn’t fall ...
(Date:5/28/2015)... 28, 2015 Today the National Resident ... for the 2015 Main Residency Match®. A record-number ... were filled when the matching algorithm was processed. ... during the Match Week Supplemental Offer and Acceptance Program® ... are pleased with the outcome of the 2015 Main ...
Breaking Medicine News(10 mins):Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 2Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 3Health News:Brooklyn Dentist Delivers Comfortable Care Through High Technology 4Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 2Health News:Second Cohort in 3D Certificate Program to Launch in August by Graduate School 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 2Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 3Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3
... 24th January 2008 - The main regulators of the ... highly involved in a large range of immune diseases. ... play a critical role in the onset of type ... Dr. Ciriaco Piccirillo, a researcher in the Department of ...
... new treatments for diabetes, researchers say , , THURSDAY, Jan. 24 ... managed to locate stem cells in the pancreas -- in ... in humans, they could pave the way for dramatic new ... the body could once again produce its own insulin. Until ...
... of consumer statutes, breach of warranty and, unjust enrichment; Damages ... of $5 billion last year, mostly paid through Medicare, Medicaid, ... other federal drug programs and private insurance, JACKSONVILLE, Fla., ... announced that they have filed a lawsuit against,Merck & Company ...
... ... to Your Neighborhood, WASHINGTON, Jan. 24 The national nonprofit,Home ... home safety exhibit -- The Great Safety Adventure.,In an effort to ... been touring the country since 1999 stopping at,elementary schools and Lowe,s ...
... During Super Bowl, WASHINGTON, Jan. 24 ... (ONDCP) is launching its first major,Federal effort to ... public awareness campaign will begin with advertising during ... TV advertising targeting,parents in nearly two years. The ...
... ... a healthy lifestyle, NEW YORK, Jan. 24 Aflac (NYSE: ... Girl. With 10 events nationwide, ranging,from 5K/10K, duathlon and triathlons, Aflac ... active lifestyle., To illustrate the collective commitment to this partnership, ...
Cached Medicine News:Health News:Deficient regulators in the immune system responsible for type 1 diabetes 2Health News:Stem Cells Finally Found in Pancreas 2Health News:Stem Cells Finally Found in Pancreas 3Health News:Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough 2Health News:Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough 3Health News:The Great Safety Adventure(R) Traveling Home Safety Exhibit Kicks Off Tenth Anniversary Tour 2Health News:The Great Safety Adventure(R) Traveling Home Safety Exhibit Kicks Off Tenth Anniversary Tour 3Health News:ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse 2Health News:ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse 3Health News:ONDCP Launches First Major Initiative to Combat Teen Prescription Drug Abuse 4Health News:Aflac to Sponsor Iron Girl 2Health News:Aflac to Sponsor Iron Girl 3
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Whole Blood Metals Control contains the major heavy metals of toxicological and environmental importance for whole blood analysis....
Lyphochek Whole Blood Control is a unique product designed to monitor immunosuppressants, red cell folate and lead in whole blood assays. This control has three critical levels for each analyte and i...
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Medicine Products: